TRIB

Trinity Biotech
TRIB

Overview Fund Trends Analyst Outlook Journalist POV

79 hedge funds and large institutions have $191M invested in Trinity Biotech in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

43% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 30

94% less call options, than puts

Call options by funds: $1K | Put options by funds: $18K

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
$18K
Net Calls
Net Calls Change

Top Buyers

1
+$2.16M
2
+$1.7M
3
+$704K
4
PCA
Prospect Capital Advisors
California
+$475K
5
BCM
Breithorn Capital Management
New York
+$353K

Top Sellers

1
-$3.26M
2
-$2.86M
3
-$1.02M
4
SC
Skylands Capital
Wisconsin
-$945K
5
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
-$904K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.55M
27
$1.5M
28
$1.23M
29
$1.22M
30
$1.03M
31
$1.02M
32
$925K
33
$922K
34
$911K
35
$778K
36
$691K
37
$659K
38
$602K
39
$506K
40
$487K
41
$425K
42
$396K
43
$386K
44
$357K
45
$357K
46
$353K
47
$338K
48
$295K
49
$286K
50
$232K
1
2
3 4